Lung Cancer Risk Calculator for Smokers
This calculator estimates your absolute risk of developing lung cancer over 6 and 16 years, based on the peer-reviewed Markaki et al. logistic regression model validated on more than 110,000 Norwegian adults. Enter your smoking history and personal details, and you receive a percentage risk estimate at both time horizons plus an instant check of USPSTF 2021 low-dose CT screening eligibility. Results update as you type.
How this calculator works
The risk estimates use the logistic regression model published by Markaki et al. and trained on data from over 65,000 Norwegian participants, then validated on a separate cohort of 45,000 people. The model applies seven key predictors: sex, age, pack-years, cigarettes per day, years since quitting, BMI, hours of daily secondhand smoke exposure, and presence of a persistent cough. Family history and occupational exposures (asbestos, radon) are incorporated as evidence-based multipliers on top of the core model, reflecting a roughly 50% and 40% relative risk increase respectively. The 6-year and 16-year outputs are absolute risks, meaning the percentage probability that you personally develop lung cancer over that period, not a relative comparison to average.
Pack-years: your cumulative smoking exposure
Pack-years is the standard clinical measure of lifetime smoking dose. One pack-year equals smoking one pack (20 cigarettes) per day for one year. So smoking half a pack a day for 30 years equals 15 pack-years. Pack-years are closely correlated with lung cancer risk because they capture both how heavily you smoked and for how long. The USPSTF uses 20 pack-years as one of its three screening eligibility thresholds (alongside age 50-80 and current or recently quit smoking status). Research from the National Lung Screening Trial showed that low-dose CT screening reduces lung cancer mortality by about 20% in adults who meet these high-risk criteria.
What the USPSTF 2021 screening criteria mean
The U.S. Preventive Services Task Force updated its lung cancer screening recommendations in 2021 to cover a broader group than its previous 2013 guidance. The new criteria: age 50 to 80, a history of at least 20 pack-years of smoking, and currently smoking or having quit within the last 15 years. Adults who meet all three criteria are recommended to have annual low-dose CT (LDCT) scans. LDCT exposes you to far less radiation than a standard chest CT and can detect small nodules before symptoms appear. However, about 25% of people screened have a finding that requires follow-up, and the vast majority of those are benign, so screening comes with trade-offs that are worth discussing with a clinician.
How quitting smoking lowers your risk over time
Lung cancer risk does not drop to never-smoker levels immediately after quitting, but it declines steadily. Within 5 years of quitting, the risk of lung cancer begins to fall relative to continuing smokers. Within 10 years it roughly halves compared to current smokers, though it remains elevated above lifetime never-smokers for 20-30 years. The chart above (for current smokers) shows the estimated divergence in your cumulative risk between continuing to smoke and quitting today. The benefit of quitting is visible even for people with many pack-years of history, which is why cessation support is the highest-value clinical intervention regardless of age or prior smoking history.
Lung cancer risk categories and screening thresholds
| 6-year risk | Category | Recommended action |
|---|---|---|
| < 0.64% | Low | Routine clinical care; continue tobacco cessation if applicable |
| 0.64% - 1.75% | Moderate | Discuss risk with doctor; evaluate USPSTF eligibility |
| 1.75% - 5% | Elevated | Likely eligible for LDCT screening; discuss with doctor |
| > 5% | High | Strongly consider LDCT screening; consult pulmonologist |
Risk categories based on the Markaki et al. model thresholds and USPSTF 2021 low-dose CT screening guidance.
Frequently asked questions
Who is this calculator designed for?
This calculator is designed for current and former smokers aged 21 to 86. The underlying Markaki et al. model was developed and validated on smoker populations. Never-smokers can still face lung cancer risk from radon, asbestos, and other causes, but no validated population-level tool in this format applies to them, and their absolute risk is generally very low (roughly 0.2% over 10 years).
What is the difference between 6-year and 16-year risk?
The 6-year risk estimates the probability of developing lung cancer in the next six years based on your current profile. The 16-year figure projects further into the future, which is useful for understanding long-term trajectories, especially if you are a younger smoker or planning cessation. Both are absolute risks, not relative risks compared to average.
Does my result change if I quit smoking?
Yes, meaningfully. In the calculator, changing your status from current to former smoker and entering years since quitting will lower both risk figures because the model applies a negative coefficient to quit-years. The longer you have been quit, the lower the calculated risk. In practice, risk reduction begins within a few years of quitting and continues for decades.
What is the 0.64% threshold for screening?
The 0.64% six-year risk threshold comes from the Markaki et al. model itself, representing the value at which the original researchers found that risk shifted from low to moderate. The USPSTF does not use a percentage threshold directly but instead uses age, pack-years, and recency of quitting. This calculator checks both.
How accurate is this tool?
The Markaki et al. model showed good discrimination (AUC approximately 0.74) in its validation cohort. However, all population-based models have limitations: they estimate average risk for people who share your risk factors, not your individual biology. Genetic susceptibility, specific occupational chemicals, indoor air quality, and other environmental factors are not captured. Use this result as a starting point for a conversation with your doctor, not as a definitive personal prediction.
Why does BMI affect lung cancer risk?
Higher BMI is associated with slightly lower lung cancer risk in smokers in epidemiological studies, which seems counterintuitive. One explanation is that low BMI can be a marker of undiagnosed disease (reverse causation), and heavy smokers tend to have lower body weight. The model reflects this statistical relationship. BMI is included for accuracy, not because fatness is protective in a simple causal sense.
Sources
- Markaki M, et al. Using Bayesian networks to model and predict lung cancer risk in smokers. Scientific Reports 2018; 8:16709.
- U.S. Preventive Services Task Force. Lung Cancer Screening: Recommendation Statement. JAMA 2021; 325(10):962-970.
- National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. NEJM 2011; 365:395-409.